Recent Advances in Understanding Cholangiocarcinoma [version 1; referees: 2 approved]
Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, cholangiocytes, and possibly de-differentiated hepatocytes. CCA has a poor overall survival rate and limited therapeutic options. Based on this data, it is imperative that new diagnostic and therapeutic i...
Main Authors: | Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Nicole Francis, Rowan Seils, Sara Villamaria, Heather Francis |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-10-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-1818/v1 |
Similar Items
-
Recent advances in understanding and managing cholestasis [version 1; referees: 2 approved]
by: Martin Wagner, et al.
Published: (2016-04-01) -
Recent advances in understanding bile acid homeostasis [version 1; referees: 2 approved]
by: John YL Chiang
Published: (2017-11-01) -
Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy [version 1; referees: 2 approved]
by: Margaret G Keane, et al.
Published: (2017-09-01) -
Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma
by: Mayur Parkhi, et al.
Published: (2023-11-01) -
Gallstones: new insights into an old story [version 1; referees: 3 approved]
by: Evan Tiderington, et al.
Published: (2016-07-01)